Revvity Inc. RVTY
- Market cap
- $16.8B
- P/E
- 72.0×
Follow RVTY
Revvity Inc. (RVTY) Price to free cash flow
As of 25 September 2026, Revvity Inc. (RVTY) trades at a price to free cash flow of 29.8×. Over the past ten years it has ranged from 0.0× (December 2023) to 2,840× (January 2024); the current reading is higher than 68% of that period. That is below the Diagnostics & Research industry median of 34.0× and above the Healthcare sector median of 19.5×.
Price to free cash flow, daily
Annual
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 22.4× | (12.44%) |
| FY2024 | 25.5× | (99.09%) |
| FY2023 | 2,808× | 9,192.01% |
| FY2022 | 30.2× | 70.76% |
| FY2021 | 17.7× | (8.45%) |
| FY2020 | 19.3× | (49.22%) |
| FY2019 | 38.1× | 12.13% |
| FY2018 | 33.9× | 4.72% |
| FY2017 | 32.4× | 89.95% |
| FY2016 | 17.1× | (26.69%) |
Quarterly
| Period | Price to free cash flow | Change |
|---|---|---|
| Jun 2026 | 22.0× | 11.34% |
| Mar 2026 | 19.7× | (11.74%) |
| Dec 2025 | 22.4× | 8.81% |
| Sep 2025 | 20.5× | (9.99%) |
| 42 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| GH Guardant Health, Inc. compare | n/m |
| TWST Twist Bioscience Corporation compare | n/m |
| ICLR ICON PLC compare | 15.0× |
| DGX Quest Diagnostics Incorporated compare | 19.4× |
| LH Labcorp Holdings Inc. compare | 24.5× |
| MEDP Medpace Holdings, Inc. compare | 24.7× |
| RVTY Revvity Inc. | 29.8× |
| MTD Mettler-Toledo International, Inc. compare | 35.2× |
| CRL Charles River Laboratories International, Inc. compare | 37.9× |
| Diagnostics & Research industry median | 34.0× |
| Healthcare sector median | 19.5× |
| Market median | 14.0× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on RVTY
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement